The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine
Related Experiment Video
Updated: Jun 1, 2026

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
Estelle Leclerc1, Claus W Heizmann
1Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58108-6050, USA. Estelle.leclerc@ndsu.edu
Abstract:
The Receptor for Advanced Glycation Endproducts (RAGE) is a multiligand receptor involved in a large number of human disorders. Identified first as the receptor for the Advanced Glycation Endproducts (AGEs), RAGE has emerged in recent years as a major receptor for many members of the S100 calcium and zinc binding protein family. The interaction with and the signaling triggered by several S100 proteins such as S100B and S100A12 have been studied in details and have shown concentration and cell type dependent signaling cascades. The S100 protein family consists of more than 20 members which present high amino-acid sequence and structural similarities. These small EF-hand calcium binding proteins interact with a large number of protein targets and are almost all been shown to be involved in cancer. In this review we discuss the recent knowledge about the role of S100 proteins and RAGE in human disorders.
Insights
The Receptor for Advanced Glycation Endproducts (RAGE) binds S100 proteins, impacting numerous human disorders. This review explores RAGE and S100 protein roles in disease, highlighting their complex signaling pathways.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Biochemistry
Background:
- The Receptor for Advanced Glycation Endproducts (RAGE) is a multiligand receptor implicated in various human diseases.
- RAGE primarily binds Advanced Glycation Endproducts (AGEs) but also interacts with the S100 protein family.
- The S100 protein family comprises over 20 small calcium-binding proteins with significant roles in cancer.
Purpose of the Study:
- To review current knowledge on the involvement of S100 proteins and RAGE in human disorders.
- To elucidate the interaction mechanisms and signaling pathways mediated by RAGE and S100 proteins.
- To highlight the implications of these interactions in disease pathogenesis.
Main Methods:
- Literature review of recent studies on RAGE and S100 proteins.
- Analysis of signaling cascades triggered by S100-RAGE interactions.
- Examination of the role of S100 proteins in cancer and other human disorders.
Main Results:
- RAGE acts as a key receptor for numerous S100 proteins, including S100B and S100A12.
- S100-RAGE interactions trigger cell-type and concentration-dependent signaling pathways.
- Many S100 proteins are implicated in cancer development and progression.
Conclusions:
- RAGE and S100 proteins are critical players in a wide range of human disorders.
- Understanding their complex interactions is crucial for developing therapeutic strategies.
- Further research into S100 protein functions and RAGE signaling is warranted.
Related Concept Videos
Translational Regulation
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Leaky Scanning
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

